MTIS 2022: Industry Symposia

Industry Symposia

Fri 9th^th Sep
Sat 10^th Sep

Friday 9th September,8:00 - 9:00

Advancing Migraine Prevention: What have we learned thus far?
Welcome and introduction
Monoclonal antibodies: their relevance in current treatment paradigm with emergence of newer therapies?
Important factors to consider in migraine treatment decision making?
What have we learned from Switching or Stopping treatments with mAbs in clinical practice?
Q&A; and close

Friday 9th September,12:00 - 13:00

Evolving faces of Migraine Dr Messoud Ashina & Dr Manjit Matharu
The many faces of migraine
Shifting paradigm in migraine management
Individualized therapy for migraine
Discussion

Friday 9th September, 17:00 - 18:00

Welcome and Introductions, Piero Barbanti (Chair)
How do we interpret personalised medicine in migraine, does it matter and is it achievable? All
Real-world insights: a gateway to personalised medicine for migraine prevention Christoph J Schankin
When one size does not fit all: what RWE teaches us about migraine prevention in individual patients Giorgio Lambru
Conclusion and Q&A;

Saturday 10th September ,11:30 - 12:30

Respecting time in migraine management
Opening remarks Patricia Pozo-Rosich (Chair)
Assessing the evidence for CGRP mAbs: What has time told us? Dagny Holle-Lee
Discussion
Changing times in migraine management: How do guidelines help? Simona Sacco
Discussion
Is it time to APPRAISE our approach to migraine prophylaxis? Patricia Pozo-Rosich
Discussion
The importance of time in patient management Teshamae Monteith
Discussion
Closing remarks

This non-promotional meeting is organised and funded by Novartis. This meeting is intended for healthcare professionals only.

Saturday 10th September ,17:30 - 18:30

Chronic Migraine: Design and Persistence in Therapy, Stewart Tepper (Chair)
To explore the typical migraine patient pathway and the important of long-term follow-up of patients with chronic migraine
To introduce sequential goal setting (SGS) and explore the potential benefits of this approach in the management of chronic migraine
To illustrate the role SGS could play within the current chronic migraine environment, which includes new preventive therapies and a focus on patient-centred care

Wednesday 7th October,18:00 - 18:30

Learning by experience - reinforcing the benefits of migraine prevention
Welcome and introduction Martin Ruttledge - Chair (Ireland)
Reinforcing the benefits of migraine prevention - the future perspective Peter McAllister (US)
Live Q&A;, moderated by Martin Ruttledge (Ireland)

Wednesday 7th October,18:30 - 20:00

Everything you always wanted to know about CGRP Monoclonal Antibodies (but were afraid to ask)
Join our expert faculty to hear them address some of the most commonly asked questions of clinicians, when it comes to CGRP mAbs, and what to consider in practice, when caring for patients.
Welcome and Introduction Mark Weatherall (UK)
Commonly Asked Questions of Clinicians When it Comes to CGRP mAbs Manjit Matharu (UK), Stewart Tepper (US) and Mark Weatherall (UK)
Live Q&A;
Closing Remarks